Sida 1 från 1762 resultat
Tissue plasminogen activator (tPA) is the only FDA-approved treatment for acute stroke, but its use remains limited. Progesterone (PROG) has shown neuroprotection in ischemia, but before clinical testing, we must determine how it affects hemorrhagic transformation in tPA-treated ischemic rats. Male
The relationship of plasma estradiol and progesterone levels to fatty liver-hemorrhagic syndrome (FLHS) was studied with three groups of 9 White Leghorn hens per group. One group was fed ad libitum the other two group were force-fed at 120% and 135% of their own pre-experimental daily feed intake.
Sequential treatment with norethisterone (NET) or natural micronized progesterone (NMP) was administered randomly to 80 consecutive patients attending our clinic because of cycle disorders. The endometrial morphology indicated a need for progestogen therapy in all cases and the endometrium was
OBJECTIVE
To verify the efficacy of moxibustion at Guanyuan (CV 4) and Shenque (CV 8) on the duration of vaginal bleeding for patients with midtrimester induction of labor and explore its mechanism.
METHODS
One hundred cases of midtrimester induction of labor were divided randomly into an
OBJECTIVE
To compare patterns of luteal phase bleeding (LPB) in IVF cycles supplemented with Crinone and with intramuscular progesterone (IMP) and to evaluate the impact of luteal estrogen supplementation on LPB.
METHODS
Prospective, randomized trial and post hoc
A woman in her late 40s presented with excessive per vagina (PV) bleeding and uterine fibroid. She reported excessive PV bleeding after starting Esmya; she was brought in by ambulance to the emergency department with profuse bleeding. Abnormal uterine bleeding (AUB) developed after selective
BACKGROUND
The purpose of the research is to study the histopathology and expression of survivin, estrogen and progesterone receptors (ER/PR) in the endometrium of patients with dysfunctional uterine bleeding (DUB) treated with radiofrequency endometrial ablation (REA).
METHODS
A total of 98 DUB
OBJECTIVE
To determine the relative influences of induction of withdrawal bleedings secretory transformation, and reduction of mitosis in glands on prevention of endometrial hyperplasia during long-term hormonal replacement therapy.
METHODS
Observational expanded clinical case
OBJECTIVE
To determine the changes in thickness and pattern of endometrium among Norplant (Leiras, Leiras Oy, Turku, Finland) users who have irregular bleeding and to correlate these changes with estradiol and progestrone concentrations.
METHODS
Ultrasonographic evaluation (vaginal ultrasound) and
Estradiol and progesterone receptor levels (RE2, RP) were measured in histologically normal endometria of women with postmenopausal bleeding (PMB) and the results were compared to those in histologically normal endometria of premenopausal and postmenopausal (PM) women and to those in pathological PM
OBJECTIVE
To investigate the serum levels of estradiol (E2) and progesterone (P) in patients with the auras of threatened abortion (ATA), i.e., fetal irritability and vaginal bleeding, and the relation with prognosis.
METHODS
Chinese medicine syndrome of 598 pregnant women with ATA consulted in
A total of 20 breastfeeding women used progesterone-releasing vaginal rings for up to 12 months. The women were divided into two groups, one (n = 9) using rings with an initial release rate of 5 mg/24 h, the other (n = 11) with a release rate of 20 mg/24 h. Individual women started to give breast
OBJECTIVE
The objective of this study was to evaluate the safety and efficacy of 2 doses of a transvaginal polycarbophil-based progesterone gel (4% and 8%) in hormone replacement therapy.
METHODS
This multicenter, randomized, parallel-group, open-label 3-month study included 127 women with secondary
OBJECTIVE
Many women are seeking alternatives to conventional forms of hormone replacement. This study evaluates the endometrial effects of natural progesterone cream used in conjunction with transdermal oestradiol.
METHODS
Open plan study conducted over 48 weeks.
METHODS
Tertiary referral London
OBJECTIVE
To compare two dosages of oral micronized progesterone (P) and placebo for withdrawal bleeding and side effects.
METHODS
Prospective, randomized, double-blind.
METHODS
Academic institution.
METHODS
Out of 190 screened with oligomenorrhea/amenorrhea, 60 who qualified completed the